Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-25

Clinical Trial Update: Effect of Evogliptin on Bone Metabolism in Human [Phase 4]

View source ↗

Summary

This Clinical Trial Update describes a Phase 4 study evaluating the effect of evogliptin on bone metabolism in individuals with Type 2 diabetes mellitus and ost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evogliptin (evogliptin)

Snippet

Sponsor: DongGuk University | Conditions: Diabetes Mellitus, Type 2, Osteoporosis | Phase 4 | Status: UNKNOWN